WallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Stock

$16.62+0.02 (0.12%)
Updated May 6, 2021
TAK Price
$16.62
Fair Value Price
N/A
Market Cap
$55.95B
52 Week Low
$15.30
52 Week High
$20.00
P/E
125.91x
P/B
1.28x
P/S
1.68x
PEG
0.44x
Dividend Yield
0%
Revenue
$30.50B
Earnings
$410.02M
Gross Margin
66.9%
Operating Margin
3.17%
Profit Margin
1.3%
Debt to Equity
1.71
Operating Cash Flow
$8B
Beta
0.59
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TAK Overview

Zen Score

High
Medium
Low
23
Industry average

Reasons for this score

TAK ($16.62) is trading below its intrinsic value of $115.49, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
TAK is poor value based on its earnings relative to its share price (125.91x), compared to the US market average (27.98x)
Valuation
TAK is poor value based on its earnings relative to its share price (125.91x), compared to the US Drug Manufacturers - Specialty & Generic industry average (40.76x)
Valuation

1 of 10

TAK News

Valuation

TAK fair value

Fair Value of TAK stock based on Discounted Cash Flow (DCF)
Price
$16.62
Fair Value
$213.03
Undervalued by
92.20%
TAK ($16.62) is trading below its intrinsic value of $115.49, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation

TAK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
125.91x
Industry
40.76x
Market
27.98x
TAK is poor value based on its earnings relative to its share price (125.91x), compared to the US market average (27.98x)
Valuation
TAK is poor value based on its earnings relative to its share price (125.91x), compared to the US Drug Manufacturers - Specialty & Generic industry average (40.76x)
Valuation

TAK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.28x
Industry
2.47x
Market
0.6x
TAK is poor value based on its book value relative to its share price (1.28x), compared to the US market average (0.6x)
Valuation
TAK is good value based on its book value relative to its share price (1.28x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.47x)
Valuation

TAK price to earnings growth (PEG)

For valuing profitable companies with growth potential
TAK is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.44x)
Valuation

TAK's financial health

Profit margin

Revenue
$30.5B
Net Income
$410.0M
Profit Margin
1.3%
TAK's Earnings (EBIT) of $965.74M are insufficient to safely cover interest payments on company debt ($51.79B)
Financials
TAK's profit margin has decreased (-5.1%) in the last year from (6.4%) to (1.3%)
Financials

Assets to liabilities

Assets
$118.8B
Liabilities
$75.0B
Debt to equity
1.18
TAK's short-term assets ($22.89B) exceed its short-term liabilities ($20.17B)
Financials
TAK's long-term liabilities ($54.84B) exceed its short-term assets ($22.89B)
Financials
TAK's debt to equity ratio (1.71) is considered high
Financials

Cash flow

Operating
$8.3B
Investing
$2.7B
Financing
-$9.3B
TAK's operating cash flow ($8.31B) may not be sufficient to safely service the company's debt ($51.79B)
Financials

Takeda Pharmaceutical Ltd Stock FAQ

What is Takeda Pharmaceutical Ltd's quote symbol?

(NYSE: TAK) Takeda Pharmaceutical Ltd trades on the NYSE under the ticker symbol TAK. Takeda Pharmaceutical Ltd stock quotes can also be displayed as NYSE: TAK.

What is the 52 week high and low for Takeda Pharmaceutical Ltd (NYSE: TAK)?

(NYSE: TAK) Takeda Pharmaceutical Ltd's 52-week high was $20.00, and its 52-week low was $15.30. It is currently -16.9% from its 52-week high and 8.61% from its 52-week low.

How much is Takeda Pharmaceutical Ltd stock worth today?

(NYSE: TAK) Takeda Pharmaceutical Ltd currently has 1,683,255,908 outstanding shares. With Takeda Pharmaceutical Ltd stock trading at $16.62 per share, the total value of Takeda Pharmaceutical Ltd stock (market capitalization) is $55.95B.

Takeda Pharmaceutical Ltd stock was originally listed at a price of $21.37 in Jan 5, 2010. If you had invested in Takeda Pharmaceutical Ltd stock at $21.37, your return over the last 11 years would have been -22.23%, for an annualized return of -2.26%.

How much is Takeda Pharmaceutical Ltd's stock price per share?

(NYSE: TAK) Takeda Pharmaceutical Ltd stock price per share is $16.62 today (as of May 6, 2021).

What is Takeda Pharmaceutical Ltd's Market Cap?

(NYSE: TAK) Takeda Pharmaceutical Ltd's market cap is $55.95B, as of May 9, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Takeda Pharmaceutical Ltd's market cap is calculated by multiplying TAK's current stock price of $16.62 by TAK's total outstanding shares of 1,683,255,908.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.